Dispersionsrot-17

Hauptinformation

  • Handelsname:
  • Dispersionsrot-17 1%, Testsalbe
  • Darreichungsform:
  • Salbe
  • Zusammensetzung:
  • 2,2'-({3-Methyl-4-[(4-nitrophenyl)diazenyl]phenyl}azandiyl)diethanol 8.48mg
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Dispersionsrot-17 1%, Testsalbe
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • PEI.D.04700.01.1
  • Letzte Änderung:
  • 03-02-2018

17-4-2018

PAIN RELIEF PATCHES (Camphor, Menthol, Methyl Salicylate) Patch [Walgreen Company]

PAIN RELIEF PATCHES (Camphor, Menthol, Methyl Salicylate) Patch [Walgreen Company]

Updated Date: Apr 17, 2018 EST

US - DailyMed

3-4-2018

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (Active substance: 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide) - Transfer of orphan designation - Commission Decision (2018)2056 of Tue, 03 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/124/12/T/01

Europe -DG Health and Food Safety

21-3-2018

EU/3/14/1363 (Quintiles Ireland Limited)

EU/3/14/1363 (Quintiles Ireland Limited)

EU/3/14/1363 (Active substance: 4-[[(1S,4S)-5-[[4-[4-(oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]hept-2-yl]methyl]benzoic acid) - Transfer of orphan designation - Commission Decision (2018)1818 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/131/14/T/01

Europe -DG Health and Food Safety

26-2-2018

EU/3/18/1988 (Chiesi Farmaceutici S.p.A.)

EU/3/18/1988 (Chiesi Farmaceutici S.p.A.)

EU/3/18/1988 (Active substance: (R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine-5-yl)phenyl)-N,N,N-trimethylethanaminium methanesulfonate dehydrate) - Orphan designation - Commission Decision (2018)1255 of Mon, 26 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/203/17

Europe -DG Health and Food Safety

26-2-2018

EU/3/18/1974 (Takeda Pharma A/S)

EU/3/18/1974 (Takeda Pharma A/S)

EU/3/18/1974 (Active substance: 6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate) - Orphan designation - Commission Decision (2018)1257 of Mon, 26 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/193/17

Europe -DG Health and Food Safety

26-2-2018

EU/3/18/1972 (CATS Consultants GmbH)

EU/3/18/1972 (CATS Consultants GmbH)

EU/3/18/1972 (Active substance: 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine-dihydrochloride) - Orphan designation - Commission Decision (2018)1256 of Mon, 26 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/202/17

Europe -DG Health and Food Safety

13-2-2018

EU/3/10/802 (Genkyotex S.A.)

EU/3/10/802 (Genkyotex S.A.)

EU/3/10/802 (Active substance: 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione) - Transfer of orphan designation - Commission Decision (2018)939 of Tue, 13 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/079/10/T/02

Europe -DG Health and Food Safety

13-2-2018

EU/3/15/1559 (Genkyotex S.A.)

EU/3/15/1559 (Genkyotex S.A.)

EU/3/15/1559 (Active substance: 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione) - Transfer of orphan designation - Commission Decision (2018)944 of Tue, 13 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/105/15/T/01

Europe -DG Health and Food Safety

6-2-2018

EU/3/07/478 (ICON Clinical Research Limited)

EU/3/07/478 (ICON Clinical Research Limited)

EU/3/07/478 (Active substance: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide) - Transfer of orphan designation - Commission Decision (2018)697 of Tue, 06 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/053/07/T/03

Europe -DG Health and Food Safety

5-2-2018

EU/3/07/526 (ICON Clinical Research Limited)

EU/3/07/526 (ICON Clinical Research Limited)

EU/3/07/526 (Active substance: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide) - Transfer of orphan designation - Commission Decision (2018)698 of Mon, 05 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/099/07/T/03

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Active substance: N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt) - Orphan designation - Commission Decision (2018)389 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/179/17

Europe -DG Health and Food Safety

17-11-2017

MUSCLE RUB ULTRA STRENGTH (Menthol And Methyl Salicylate) Cream [Natureplex LLC]

MUSCLE RUB ULTRA STRENGTH (Menthol And Methyl Salicylate) Cream [Natureplex LLC]

Updated Date: Nov 17, 2017 EST

US - DailyMed

10-11-2017

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Active substance: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione) - Orphan designation - Commission Decision (2017)7555 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/142/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1942 (Celleron Therapeutics Limited)

EU/3/17/1942 (Celleron Therapeutics Limited)

EU/3/17/1942 (Active substance: N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide) - Orphan designation - Commission Decision (2017)7564 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/121/17

Europe -DG Health and Food Safety

18-10-2017

EU/3/17/1916 (Voisin Consulting S.A.R.L.)

EU/3/17/1916 (Voisin Consulting S.A.R.L.)

EU/3/17/1916 (Active substance: 5-amino-1-(2-methyl-1H-benzo[d]imidazol-5-yl)-1H-pyrazol-4-yl 1H-indol-2-yl ketone mono[(S)-2-hydroxysuccinate]) - Orphan designation - Commission Decision (2017)7049 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/124/17

Europe -DG Health and Food Safety

25-8-2017

EU/3/17/1902 (Eisai Europe Limited)

EU/3/17/1902 (Eisai Europe Limited)

EU/3/17/1902 (Active substance: N-{2-[(6-{[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4-yl)amino]-5-(4-ethylpiperazin-1-yl)phenyl}prop-2-enamide) - Orphan designation - Commission Decision (2017)5911 of Fri, 25 Aug 2017 European Medicines Agency (EMA) procedure number: EMA/OD/052/17

Europe -DG Health and Food Safety

19-7-2017

EU/3/17/1889 (PhaRA bvba)

EU/3/17/1889 (PhaRA bvba)

EU/3/17/1889 (Active substance: (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine) - Orphan designation - Commission Decision (2017)5153 of Wed, 19 Jul 2017 European Medicines Agency (EMA) procedure number: EMA/OD/037/17

Europe -DG Health and Food Safety

23-5-2017

EU/3/17/1873 (Best Regulatory Consulting Ltd)

EU/3/17/1873 (Best Regulatory Consulting Ltd)

EU/3/17/1873 (Active substance: Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain) - Orphan designation - Comm...

Europe -DG Health and Food Safety